Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The genetic landscape and possible therapeutics of neurofibromatosis type 2. | Cancer Cell Int | 2023 | 37217995 | PubTator, text mining | PubMed |
| Nationwide genetic analysis of more than 600 families with inherited eye diseases in Argentina. | NPJ Genom Med | 2023 | 37217489 | PubTator, text mining | PubMed |
| Potency testing of cell and gene therapy products. | Front Med (Lausanne) | 2023 | 37215709 | PubTator, text mining | PubMed |
| Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO. | Ophthalmol Ther | 2023 | 37210697 | PubTator, text mining | PubMed |
| Luteolin inhibits subretinal fibrosis and epithelial-mesenchymal transition in laser-induced mouse model via suppression of Smad2/3 and YAP signaling. | Phytomedicine | 2023 | 37201365 | PubTator, text mining | PubMed |
| SCX-tip-aided LC-MS detection of active ricin via oligonucleotide substrates for depurination kinetics. | Analyst | 2023 | 37195783 | PubTator, text mining | PubMed |
| Optical Coherence Tomography and Optical Coherence Tomography Angiography in Pediatric Retinal Diseases. | Diagnostics (Basel) | 2023 | 37189561 | PubTator, text mining | PubMed |
| CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma. | Mol Med | 2023 | 37183261 | PubTator, text mining | PubMed |
| Clinical applications of gene therapy for rare diseases: A review. | Int J Exp Pathol | 2023 | 37177842 | PubTator, text mining | PubMed |
| Comparison of Fucoidans from Saccharina latissima Regarding Age-Related Macular Degeneration Relevant Pathomechanisms in Retinal Pigment Epithelium. | Int J Mol Sci | 2023 | 37175646 | PubTator, text mining | PubMed |
| Viral Vector-Based Gene Therapy. | Int J Mol Sci | 2023 | 37175441 | PubTator, text mining | PubMed |
| Retinal Cell Damage in Diabetic Retinopathy. | Cells | 2023 | 37174742 | PubTator, text mining | PubMed |
| CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells. | Sci Adv | 2023 | 37172090 | PubTator, text mining | PubMed |
| A nonsense mutation in C8orf37 linked with retinitis pigmentosa, early macular degeneration, cataract, and myopia in an arRP family from North India. | BMC Ophthalmol | 2023 | 37170250 | PubTator, text mining | PubMed |
| Spatiotemporal Coordination of RPE Cell Quality by Extracellular Vesicle miR-494-3p Via Competitive Interplays With SIRT3 or PTEN. | Invest Ophthalmol Vis Sci | 2023 | 37163276 | PubTator, text mining | PubMed |
| Altered zinc homeostasis in a primary cell culture model of the retinal pigment epithelium. | Front Nutr | 2023 | 37139441 | PubTator, text mining | PubMed |
| Protective effects of Scoparia dulcis L. extract on high glucose-induced injury in human retinal pigment epithelial cells. | Front Nutr | 2023 | 37139437 | PubTator, text mining | PubMed |
| The genetic landscape of inherited retinal dystrophies in Arabs. | BMC Med Genomics | 2023 | 37127645 | PubTator, text mining | PubMed |
| CRISPR editing demonstrates rs10490924 raised oxidative stress in iPSC-derived retinal cells from patients with ARMS2/HTRA1-related AMD. | Proc Natl Acad Sci U S A | 2023 | 37126685 | PubTator, text mining | PubMed |
| IMI-Management and Investigation of High Myopia in Infants and Young Children. | Invest Ophthalmol Vis Sci | 2023 | 37126360 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=20